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Melanocortin 4 receptors (MC4Rs) in the central
nervous system are key regulators of energy and
glucose homeostasis. Notably, obese patients with
MC4R mutations are hyperinsulinemic and re-
sistant to obesity-induced hypertension. Although
these effects are probably dependent upon the
activity of the autonomic nervous system, the
cellular effects of MC4Rs on parasympathetic and
sympathetic neurons remain undefined. Here, we
show that MC4R agonists inhibit parasympathetic
preganglionic neurons in the brainstem. In contrast,
MC4R agonists activate sympathetic preganglionic
neurons in the spinal cord. Deletion of MC4Rs in
cholinergic neurons resulted in elevated levels of
insulin. Furthermore, re-expression of MC4Rs
specifically in cholinergic neurons (including sym-
pathetic preganglionic neurons) restores obesity-
associated hypertension in MC4R null mice. These
findings provide a cellular correlate of the auto-
nomic side effects associated with MC4R agonists
and demonstrate a role for MC4Rs expressed in
cholinergic neurons in the regulation of insulin
levels and in the development of obesity-induced
hypertension.INTRODUCTION
Obesity is correlated with an increased incidence of diabetes
and hypertension while weight loss is often associated with
decreases in blood glucose and blood pressure. A potential
mediator of these processes is the central melanocortin system,
which regulates food intake, energy expenditure, body weight,612 Cell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc.and glucose homeostasis via distinct projection patterns to mel-
anocortin receptors in hypothalamic and extrahypothalamic
nuclei (Cone, 2005). Importantly, mutations in melanocortin 4
receptors (MC4Rs) predispose both rodents and humans to
obesity and diabetes independent of hypertension (Fan et al.,
1997; Huszar et al., 1997; Tallam et al., 2005; Vaisse et al.,
1998; Yeo et al., 1998). Moreover, MC4R agonists elevate blood
pressure by increasing sympathetic activity (Greenfield et al.,
2009; Kuo et al., 2004; Ni et al., 2006). Collectively, these findings
predict that MC4Rs directly regulate autonomic neurons and
potentially contribute to obesity-induced hypertension. More-
over, understanding the neurobiological mechanisms underlying
MC4R activation in a distributed network of neurons (including
the autonomic nervous system) may facilitate the advancement
of novel treatments to prevent and/or treat obesity and its
comorbidities.
Recent work demonstrated that re-expression of MC4Rs in
the forebrain, including the paraventricular nucleus of the hypo-
thalamus (PVH), and in the amygdala normalized the hyper-
phagia observed in MC4R null mice (Balthasar et al., 2005).
This result was independent of effects on energy expenditure
and glucose homeostasis (Balthasar et al., 2005). On the other
hand, re-expression of MC4Rs in autonomic neurons normalized
energy expenditure and glucose homeostasis (Rossi et al.,
2011). Notably, MC4Rs restricted to the dorsal motor nucleus
of vagus (DMV) have been suggested to regulate insulin secre-
tion, while MC4Rs in the intermediolateral column (IML) modu-
late energy expenditure (Rossi et al., 2011). MC4R agonists
lead to acute activation of neurons within the PVH and the dorso-
medial nucleus of the hypothalamus (DMH) (Liu et al., 2003).
Thus, direct activation of autonomic neurons expressing
MC4Rs may lead to alterations in energy balance and glucose
homeostasis. However, the physiological effects of activating
both arms of the autonomic nervous system at the same time
are not readily apparent. To address this issue, we assessed
the cellular effects of MC4R agonists on parasympathetic and
sympathetic neurons.
Figure 1. Parasympathetic Preganglionic
Neurons of DMV Are Directly Inhibited by
MC4Rs
(A–D) Brightfield illumination (A), fluorescent
(TRITC) illumination (B), fluorescent (FITC) illumi-
nation (C), and merged image of targeted DMV
cholinergic neuron (D, arrow indicates the targeted
cell). Scale bar = 50 mm.
(E) Post hoc identification of recorded neuron
within the DMV. Scale bar = 500 mm.
(F) Image demonstrates an MTII-induced hyper-
polarization of DMV cholinergic neurons. Dashed
line indicates the resting membrane potential.
(G) MTII hyperpolarized cholinergic neurons in the
presence of TTX and fast synaptic blockers
(CNQX, AP-5, picrotoxin).
(H) Histogram shows membrane potential
changes of DMV cholinergic neurons. Numbers in
parentheses indicate number of cells tested.
Results are shown as means ± SEM. ** indicates
p < 0.01.
(I) Images show the location of MTII-inhibited
cholinergic neurons within the DMV (blue dots).
4V = fourth ventricle, AP = area postrema, CC =
central canal, Cu = nucleus cuneatus, DMV =
dorsal motor nucleus of vagus nerve, Gr = nucleus
gracilis, and NTS = nucleus tractus solitarius.
See also Figure S1.RESULTS
MC4R Agonists Directly Inhibit Cholinergic
Parasympathetic Preganglionic Neurons
in the Brainstem
We used choline acetyltransferase (ChAT)-Cre::tdtomato re-
porter mice (Rossi et al., 2011) to examine the role of MC4Rs
in acutely regulating the cellular activity of cholinergic neurons
in the DMV. Acute coronal brainstem slices containing the
DMV were prepared (Figures S1A and S1B) for electrophysio-
logical recordings (Figures 1A–1D). In current clamp mode,
MTII (an MC3R/4R agonist) hyperpolarized the membrane
potential of cholinergic neurons within the DMV by 6.9 ±
0.4 mV (6/16, 37.5%; Figures 1F and 1H). The MTII-induced
hyperpolarization was also observed in the presence of tetrodo-
toxin (TTX; 0.5 mM) and a cocktail of fast synaptic blockers
(10 mM CNQX + 50 mM AP-5 + 50 mM picrotoxin), indicative
of a postsynaptic mechanism (8.3 ± 1.2 mV, n = 5, t(9) =
1.175; Figures 1G and 1H). Subsequent to the recordings,
slices were fixed in order to identify the location of recorded
cholinergic neurons within the rostrocaudal and mediolateral
axis of DMV (Figure 1E). MTII-inhibited cholinergic neuronsCell 152, 612–619were located medially throughout the
rostrocaudal axis of DMV (Figure 1I),
and this pattern was conserved when
pretreated by TTX/synaptic blockers
(Figure S1C).
In order to further confirm the involve-
ment MC4Rs, we generated mice in
which cholinergic neurons were defi-
cient in MC4Rs (ChAT-Cre::tdtomato::Mc4rflox/flox, see Experimental Procedures). Biophysical proper-
ties of ChAT-Cre::tdtomato::Mc4rflox/flox cholinergic neurons
were similar to wild-type cholinergic neurons (Figure 2A).
Importantly, MTII failed to hyperpolarize the membrane poten-
tial of all DMV cholinergic neurons targeted from ChAT-Cre::
tdtomato::Mc4rflox/flox mice (0.1 ± 0.1 mV, n = 18, t(22) =
21.53; Figures 2B, 2C, and 1H). MC4Rs are coupled to Gs
proteins (Mountjoy et al., 1994), which classically activate the
adenylyl cyclase (AC)/cyclic AMP (cAMP)/protein kinase A
(PKA) signaling pathways (Flagg et al., 2010). We confirmed
that intracellular signaling pathways downstream of MC4Rs
remained intact as pharmacological activation of AC/PKA by
forskolin (10 mM) inhibited as well as activated cholinergic
DMV neurons from ChAT-Cre::tdtomato::Mc4rflox/flox mice
(Figures S2A and S2B). In a separate series of experiments,
the MC4R-specific agonist, THIQ (100 nM), mimicked the
hyperpolarizing effect of MTII (Figures S3A, S3D, and S3G).
Similar to the effects of MTII, THIQ failed to influence the
membrane potential of cholinergic neurons from ChAT-Cre::
tdtomato::Mc4rflox/flox mice (Figures S3E–S3G). Together, these
data support an MC4R-dependent hyperpolarization of cholin-
ergic neurons within the DMV., January 31, 2013 ª2013 Elsevier Inc. 613
Figure 2. MC4R-Dependent Acute Inhibi-
tion of DMV Cholinergic Neurons
(A) Histograms demonstrating that cell capaci-
tance, membrane potential, and input resistance
were not significantly different between wild-
type (gray) and MC4R-deficient (white) DMV
cholinergic neurons. Results are shown as
means ± SEM.
(B) MTII did not hyperpolarize cholinergic neurons
in mice deficient for MC4Rs in ChAT-positive
neurons.
(C) Drawings illustrate the location and the acute
effect of MTII on targeted MC4R-deficient DMV
cholinergic neurons.
See also Figures S2 and S3.MC4R Agonists Inhibit DMV Cholinergic Neurons via
a cAMP/PKA-Dependent Activation of a KATP Channel
The MTII-induced hyperpolarization of DMV cholinergic neurons
was accompanied by a 16.8% ± 3.4% decrease in input
resistance (n = 6, from 1,047 ± 75 MU to 871 ± 72 MU;
Erev =106.1 ± 5.8mV), suggesting the activation of a potassium
channel (Figures 3B, 3C, and 3E). Moreover, the specific KATP
channel inhibitor tolbutamide (200 mM) completely reversed the
MTII-induced hyperpolarization in cholinergic DMV neurons (Fig-
ure 3A). Similar results were obtained with MTII in TTX/synaptic
blockers (Figure 3E) and THIQ (Figures S3B, S3C, and S3H).
Thus, MC4Rs inhibit cholinergic neurons in the DMV via activa-
tion of a putative KATP channel. Importantly, Gs protein-coupled
receptors (GsPCRs) have been shown to cause vasodilation by
activating KATP channels in vascular smooth muscle cells (Flagg
et al., 2010; Quinn et al., 2004); however, this is the first demon-
stration of a similar mechanism within the CNS.
In order to examine the components of the signaling cascade
in the GsPCR-coupled inhibition of DMV cholinergic neurons, we
first examined whether direct activation of AC (using 10 mM
forskolin) or PKA (using 500 mM8-Br-cAMP) inhibited cholinergic
neurons within the DMV. Similar to the effects of MTII and THIQ,
superfusion of the AC activator (forskolin) hyperpolarized cholin-
ergic neurons within the DMV (8.1 ± 1.1 mV, 4 of 10; Figures614 Cell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc.S4A–S4C). Moreover, the PKA activator
(8-Br-cAMP) hyperpolarized DMV cholin-
ergic neurons (8.2 ± 1.2 mV, 4 of 11;
Figures S4D–S4F). The forskolin- and 8-
Br-cAMP-induced hyperpolarization was
completely reversed in the presence of
tolbutamide, supporting the involvement
of a putative KATP channel. Interestingly,
in both experiments one cell was depolar-
ized by either forskolin (Figures S4B and
S4C) or 8-Br-cAMP (Figures S4E and
S4F), suggesting that GsPCRs other
than MC4Rs may activate cholinergic
neurons within the DMV, as previously
described (Wan et al., 2007). Pharmaco-
logical inhibition of PKA with either 1 mM
H-89 or 100 nM KT-5720 completely
blocked the MTII-induced hyperpolariza-tion (Figures 1H, 3D, 3E, and S5). Together, these data suggest
that MC4Rs activate postsynaptic PKA signaling pathways that
open putative KATP channels ultimately leading to a direct
hyperpolarization (inhibition) of parasympathetic preganglionic
neurons in the DMV.
MC4R Agonists Suppress Excitatory Presynaptic Inputs
to DMV Cholinergic Neurons
Recent evidence suggests that presynaptic terminals within the
dorsal vagal complex (DVC) contain MC3R/4Rs (Wan et al.,
2008). Thus, we tested the possibility that in addition to the direct
postsynaptic effects of MC4Rs on DMV cholinergic neurons,
MC4R agonists may also inhibit DMV cholinergic neurons via
presynaptic mechanisms. We recorded miniature excitatory
and inhibitory postsynaptic currents (mEPSCs and mIPSCs)
using Cs+-based pipette solutions (see Experimental Proce-
dures). The mEPSC frequency was 2.3 ± 0.7 Hz (n = 14)
throughout the rostrocaudal axis of DMV (Table 1). The MC4R-
specific agonist, THIQ (100 nM), significantly decreased the
frequency of mEPSCs in 9 of 14 cells recorded (from 3.0 ±
1.0 Hz in control ACSF to 2.1 ± 0.9 Hz in THIQ; 30% decrease,
t(8) = 6.402 by paired t test, Table 1 and Figure S6A). The overall
frequency of mEPSCs in the population was also significantly
reduced in response to THIQ (t(13) = 5.214 by paired t test),
Figure 3. PKA-Dependent KATP Channel
Activation Underlies the Acute Inhibition of
DMV Neurons by MC4Rs
(A) Trace showing that MTII-induced hyperpolar-
ization was completely reversed by tolbutamide.
Arrows indicate interruption to apply current step
pulses.
(B and C) MTII-induced decrease in input resis-
tance as determined by small hyperpolarizing
steps.
(D) MTII did not hyperpolarize cholinergic neurons
when pretreated with H-89.
(E) Histogram shows input resistance changes of
DMV cholinergic neurons. Numbers in paren-
theses indicate number of cells tested. Results are
shown asmeans ±SEM. * indicates p < 0.05 and **
indicates p < 0.01.
See also Figures S4 and S5.whereas the mean amplitude of mEPSCs was unaffected (t(13) =
0.1705 by paired t test). In contrast, THIQ either increased (three
cells) or decreased (two cells) the frequency of mIPSCs (Fig-
ure S6B). The overall frequency and amplitude of mIPSCs in the
population of recorded DMV cholinergic neurons were not signif-
icantly affected by THIQ (t(12) = 0.3474 and t(12) = 0.7079, respec-
tively, by paired t test, Table 1). Interestingly, forskolin (10 mM)
mimicked the effect of THIQ on mEPSCs frequency in three out
of eight cells tested (45%decrease; Figure S6C). In the remaining
neurons, mEPSC frequency was increased in one cell (65%) and
was unchanged in the remaining four cells. These data support
a model of an MC4R/cAMP-dependent decrease in excitatory
tone toDMVcholinergic neurons,whichcontributes toasuppres-
sion of DMV cholinergic neuronal excitability.
MC4R Agonists Directly Activate Cholinergic
Sympathetic Preganglionic Neurons in the Spinal Cord
We used ChAT-Cre::tdtomato reporter mice (Rossi et al., 2011)
to examine the role of MC4Rs in acutely regulating the cellular
activity of cholinergic neurons in the IML. Acute coronal spinal
cord slices containing the IML (Figure S7A) were prepared for
electrophysiological recordings (Figures 4A–4E). In contrast to
the effects observed in DMV cholinergic neurons (Figures 1
and 3), but in agreement with results from neurons within the
hypothalamus (Liu et al., 2003; Smith et al., 2007), the MC4R-
specific agonist THIQ depolarized the membrane potential of
IML cholinergic neurons (5 of 14; 5.4 ± 0.4 mV, Figures 4F and
4J). The depolarization by THIQ was accompanied by a
21.4% ± 2.0% decrease in input resistance (n = 5, from
962.4 ± 153.9 MU to 764.6 ± 128.1 MU; Erev = 26.5 ±
2.4 mV), suggesting an activation of a putative nonselectiveTable 1. Effects of MC4R-Specific Agonist on Miniature
Postsynaptic Currents Recorded from DMV Cholinergic Neurons
Frequency (Hz) Mean Amplitude (pA)
Control THIQ Control THIQ
mEPSC (n=14) 2.3 ± 0.7 1.6 ± 0.6** 13.0 ± 0.9 12.8 ± 0.8
mIPSC (n=13) 1.2 ± 0.5 1.3 ± 0.6 14.2 ± 1.1 13.8 ± 1.1
See also Figure S6. ** indicates p<0.01 vs. control.cation conductance by THIQ (Figures 4H, 4I, and 4K). The
THIQ-induced depolarization (4 of 10; 5.1 ± 0.2 mV, t(7) =
0.6504) and decrease in input resistance (22.9% ± 3.3%, n =
4, t(7) = 0.4114, from 1,329.8 ± 174.6 MU to 1,020.5 ± 133.1
MU; Erev = 27.8 ± 3.5 mV) was also apparent in the presence
of TTX and synaptic blockers, indicating a direct postsynaptic
MC4R agonist-induced activation of IML cholinergic neurons
(Figures 4G, 4J, and 4K). THIQ-activated cholinergic neurons
were located medially within the IML, which was also conserved
in slices pretreated with TTX and synaptic blockers (Figures S7B
and S7C). These data demonstrate that MC4Rs activate a puta-
tive nonselective cationic channel that directly depolarizes (acti-
vates) sympathetic preganglionic neurons of IML.
MC4Rs Specifically Expressed on Cholinergic Neurons
Regulate Blood Pressure and Insulin Levels
Electrophysiological data suggest that MC4R signaling in cholin-
ergic neurons decreases parasympathetic preganglionic
neuronal activity in the brainstem while increasing sympathetic
preganglionic neuronal activity in the spinal cord. To investigate
the physiological effect of MC4R-mediated regulation of the
autonomic nervous system in vivo, we measured mean arterial
pressure in freely moving mice either lacking all MC4Rs
(loxTB MC4R, Balthasar et al., 2005) or expressing MC4Rs
only in Sim1-positive (Sim1-Cre, loxTB MC4R: PVH/amygdala,
Balthasar et al., 2005) or ChAT-positive (ChAT-Cre, loxTB
MC4R: cholinergic, Rossi et al., 2011) neurons, using radiotelem-
etry methods. Consistent with findings in MC4R knockout mice
(Tallam et al., 2005) and obese human patients with MC4Rmuta-
tions (Greenfield et al., 2009), we confirmed that mice lacking
MC4Rs (loxTBMC4Rmice) do not develop hypertension despite
their obesity (black bars, Figures 5A and 5B). Interestingly, in
contrast to Sim1-Cre, loxTB MC4R mice (light gray bars),
ChAT-Cre, loxTB MC4R mice (dark gray bars) develop obesity-
induced hypertension, which is only apparent during the animals’
active nocturnal period (Figures 5A and 5B).
We previously demonstrated that reactivation of MC4Rs
specifically in the cholinergic neurons normalizes hyperinsuline-
mia characteristic of MC4R deficiency (Rossi et al., 2011). In this
study, we assessed the requirement of MC4Rs in the regulation
of insulin levels. Selective deletion of MC4Rs in cholinergicCell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc. 615
Figure 4. Sympathetic Preganglionic Neu-
rons of IMLAreDirectly Activated byMC4Rs
(A–D) Brightfield illumination (A), fluorescent
(TRITC) illumination (B), fluorescent (FITC) illumi-
nation (C), and merged image of targeted cholin-
ergic IML neuron (D, arrow indicates the targeted
cell). Scale bar = 50 mm.
(E) Post hoc identification of recorded neuron
within IML. Scale bar = 500 mm.
(F) Trace shows a THIQ-induced depolarization of
IML cholinergic neurons. Dashed line indicates the
resting membrane potential.
(G) THIQ depolarized cholinergic neurons in the
presence of TTX and fast synaptic blockers
(CNQX, AP-5, picrotoxin).
(H and I) THIQ induced decrease in input resis-
tance as determined by hyperpolarizing current
steps.
(J and K) Histogram illustrates changes in
membrane potential and input resistance of IML
cholinergic neurons. Numbers in parentheses
indicate number of cells tested. Results are shown
as means ± SEM. See also Figure S7.neurons (ChAT-Cre::Mc4rflox/flox) resulted in significantly higher
plasma insulin levels compared to weight-matched controls
(Mc4rflox/flox; t(14) = 7.396, Figure S2C). These results suggest
that MC4Rs expressed by the cholinergic neurons are key regu-
lators of blood insulin levels.
Discussion
In summary, these data demonstrate that MC4R agonists
inhibit parasympathetic preganglionic neuronal activity while
increasing sympathetic preganglionic neuronal activity through
novel cellular mechanisms within the CNS (Figure 6). Notably,
while Gs-coupled GPCRs in the CNS typically increase cellular
and/or synaptic activity (Acuna-Goycolea and van den Pol,
2004; Dio´genes et al., 2004; Lin et al., 2003; Liu et al., 2003;
Pascoli et al., 2012; Smith et al., 2007; Wan et al., 2008; Wan
et al., 2007), it is of particular interest that MC4Rs directly hyper-
polarize DMV cholinergic neurons via cellular mechanisms iden-
tical to those found in vascular smooth muscle cells (Flagg et al.,
2010; Quinn et al., 2004). Furthermore, we demonstrate that
MC4R-mediated regulation of the autonomic nervous system
plays a crucial role in the development of obesity-induced hyper-
tension as well as the regulation of insulin levels.
Recent work demonstrated that mutations in MC4Rs
resulted in obesity. However, the prevalence of hypertension
was lower than in weight-matched obese patients without616 Cell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc.MC4Rmutations, suggesting aprotection
against obesity-induced hypertension in
MC4R mutant patients (Greenfield et al.,
2009). Moreover, recent work suggests
that stimulation of MC4Rs in obese
patients is associated with hypertension
(Greenfield et al., 2009). In support of
these data, the present study suggests
that stimulation of MC4Rs increases
sympathetic tone which has been corre-lated with elevated blood pressure (Kuo et al., 2004; Ni et al.,
2006). Indeed, re-expression of MC4Rs specifically in cholin-
ergic neurons renders MC4R null mice hypertensive. Given our
cellular data, it is likely that this is due to spinal cordMC4R-medi-
ated increases in sympathetic tone. Re-expression of MC4Rs in
Sim1-positive PVH/amygdala neurons had no effect on mean
arterial pressure; note, however, that these mice are also not
obese.
Obese children with MC4R mutations have elevated insulin
levels (Farooqi et al., 2003). Interestingly, MC4Rs have also
been suggested to regulate the release of insulin via the activity
of sympathetic neurons (Fan et al., 2000; Obici et al., 2001).
Moreover, recent evidence suggests an important role for
MC4Rs in the DVC to regulate insulin secretion (Rossi et al.,
2011). Consistent with this model, the present study suggests
that activation of MC4Rs decreases parasympathetic tone,
which may result in decreased insulin secretion. Importantly,
we found that selective loss of MC4Rs in cholinergic neurons
blunted the acute effects of MC4R agonists on cellular activity
and also resulted in hyperinsulinemia.
Together, these data demonstrate a reciprocal regulation of
sympathetic and parasympathetic activity by MC4Rs. These
findings provide further evidence for the effects of MC4Rs in
the autonomic nervous system to decrease insulin secretion
while increasing energy expenditure and blood pressure. These
Figure 5. Re-expression of MC4Rs Specifi-
cally on Cholinergic Neurons Renders
Mice Hypertensive
(A) Body weight data (means ± SEM). n = 5–9 per
group, one-way ANOVA ***p < 0.001.
(B) Radiotelemetry recordings in ad libitum chow
fed, freely moving 8–10 week-old wild-type, loxTB
MC4R, Sim1-cre, loxTB MC4R, and ChAT-Cre,
loxTB MC4R mice. Measurements were taken for
5min every hour over a 72 hr period; presented are
average (means ± SEM) light- and dark-phase
values for mean arterial pressure. (n = 5–9 per
group, *p < 0.05 two-way repeated-measures
ANOVA).data also provide amolecular and cellular mechanism for the role
of MC4Rs in the regulation of the autonomic nervous system.
Notably, these cellular/molecular observations are linked to
physiological outcomes and demonstrate that MC4Rs on cholin-
ergic neurons indeed play an important role in obesity-induced
hypertension. Consequently, these observations may contribute
to the development of novel therapeutic strategies in the treat-
ment of obesity and associated comorbidities such as diabetes
and hypertension.EXPERIMENTAL PROCEDURES
Mice
Mice in which Cre expression was restricted to cholinergic neurons (ChAT-
IRES-Cre or ChAT-Cre mice) (Rossi et al., 2011) were mated with tdtomato
reporter mouse (Jackson Laboratory, #007908) in order to identify the auto-
nomic preganglionic neurons. For some experiments, ChAT-Cre::tdtomato
reporter mice or ChAT-Cre mice were subsequently mated with Mc4rflox/floxFigure 6. The Central Melanocortin System Decreases Para-
sympathetic Activity and Increases Sympathetic Activity via Direct
Activation of MC4Rs
The central melanocortin system innervates parasympathetic preganglionic
(DMV) and sympathetic preganglionic (IML) neurons, both of which express
MC4Rs. DMV cholinergic neurons are inhibited by MC4Rs via a PKA-depen-
dent activation of putative KATP channels, whereas IML cholinergic neurons
are activated via anMC4R-induced activation of a putative nonselective cation
channel. The altered cellular activity supports an MC4R-dependent suppres-
sion of parasympathetic activity and enhancement of sympathetic activity,
which has implications for a variety of disease states including diabetes and
hypertension.mice in order to generate mice selectively deficient in MC4Rs in cholinergic
neurons. Mc4rflox/flox mice were made by inserting loxP sites to flank the single
exon (50 loxP site into 50UTR—similar to where the loxTB cassette sits in the
loxTB MC4R mouse—the 30 loxP site sits after the 30UTR). Mc4rflox/flox homo-
zygous mice were bred to EIIA-Cre to produce MC4R null mice (Mc4rD/D).
Mc4rD/D mice were obese with increased linear length and lean mass, similar
to what was reported for MC4R null mice (Huszar et al., 1997) and also for
the loxTB MC4R mice (Balthasar et al., 2005). A full description of the
Mc4rflox/flox mice will appear in a subsequent manuscript by L.V. and B.B.L.
All mice used for electrophysiological recordings were housed in a light-dark
(12 hr on/off; lights on at 7:00 a.m.) and temperature-controlled environment
with food and water available ad libitum in the University of Texas South-
western Medical Center Facility. For radiotelemetry, the loxTB MC4R (Baltha-
sar et al., 2005), Sim1-Cre, loxTB MC4R (Balthasar et al., 2005), and ChAT-
Cre, loxTB MC4R (Rossi et al., 2011) mice and their wild-type littermates
were maintained on a mouse chow (2016 Teklad Global 16% Protein Rodent
Diet, Harlan, UK) at the University of Bristol Facility. All experiments were per-
formed in accordance with the guidelines established by the National Institute
of Health Guide for the Care and Use of Laboratory Animals, the University of
Texas Southwestern Medical Center Institutional Animal Care and Use
Committee, the UK Animals (Scientific Procedures) Act, and the University
of Bristol Ethical Review Group.
Electrophysiology
Whole-cell patch-clamp recordings from cholinergic neurons maintained in
brainstem or thoracic spinal cord slice preparations were performed as previ-
ously described (Hill et al., 2008; Wang et al., 2008; Williams and Smith, 2006;
Williams et al., 2007). Briefly, 4- to 14-week-old male mice were deeply anes-
thetized with i.p. injection of 7% chloral hydrate and transcardially perfused
with a modified ice-cold artificial cerebrospinal fluid (ACSF) (described below),
in which an equiosmolar amount of sucrosewas substituted for NaCl. Themice
were then decapitated, and the entire brainstem or thoracic spinal cord was
removed and immediately submerged in ice cold, carbogen-saturated
(95% O2 and 5% CO2) ACSF (126 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl2,
2.5 mM CaCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 5 mM glucose). A
brain block containing the brainstem or thoracic spinal cord glued to agarose
blocks was mounted on a stage. Coronal sections (200–350 mm) were cut from
either the medulla oblongata containing the DMV or the upper thoracic spinal
cord containing the IMLwith a Leica VT1000S Vibratome and then incubated in
oxygenated ACSF at room temperature for at least 1 hr before recording.
Slices were transferred to the recording chamber and allowed to equilibrate
for 10–20 min before recording. The slices were bathed in oxygenated ACSF
(32C–34C) at a flow rate of 2 ml/min.
The pipette solution for current-clamp whole-cell recording was modified to
include an intracellular dye (Alexa Fluor 488): 120 mM K-gluconate, 10 mM
KCl, 10 mM HEPES, 5 mM EGTA, 1 mM CaCl2, 1 mM MgCl2, 2 mM MgATP,
and 0.03 mM Alexa Fluor 488 hydrazide dye (pH 7.3). K-gluconate was re-
placed by equimolar Cs-gluconate for voltage-clamp experiments recording
mEPSCs and mIPSCs. Epifluorescence was briefly used to target fluorescent
cells, at which time the light source was switched to infrared differential
interference contrast imaging to obtain the whole-cell recording (Zeiss
Axioskop FS2 Plus or Nikon Eclipse FN1 equipped with a fixed stage and aCell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc. 617
QuantEM:512SC electron-multiplying charge-coupled device camera). Elec-
trophysiological signals were recorded using an Axopatch 700B amplifier
(Molecular Devices), low-pass filtered at 2–5 kHz, and analyzed offline on
a PC with pCLAMP programs (Molecular Devices). Recording electrodes
had resistances of 2.5–5 MUwhen filled with the K-gluconate or Cs-gluconate
internal solutions. mEPSCs were recorded as inward currents at a holding
potential of 60 mV, and mIPSCs were recorded as outward currents at
a holding potential of 10 mV, as described previously (Williams and Smith,
2006; Williams et al., 2007). Input resistance was assessed by measuring
voltage deflection at the end of the response to hyperpolarizing rectangular
current pulse steps (500 ms of 10 to 50 pA). Membrane potential values
were compensated to account for junction potential (8 mV).
MTII (100 nM, Bachem) and THIQ (100 nM, Tocris) were added to the ACSF
for specific experiments. Solutions containing MTII or THIQ were typically
perfused for 3–5 min. A drug effect was required to be associated temporally
with peptide application, and the response had to be stable within a few
minutes. A neuron was considered depolarized or hyperpolarized if a change
in membrane potential was at least 2 mV in amplitude. After recording, slices
were fixed with 4% formalin in PBS at 4C overnight. After washing in PBS,
slices were mounted onto slides, covered in Vectashield (Vector Laboratories),
and coverslipped to reduce photo-oxidation during visualization with fluores-
cent light. Cells were then visualized with ApoTome imaging system (Imager
Z1; Zeiss) to identify post hoc the anatomical location of the recorded neuron
within the DMV or the IML.
Drugs
TTX, H-89, KT-5702, forskolin, and 8-Br-cAMP were obtained from Tocris.
CNQX, AP-5, and picrotoxin were obtained from Sigma. All solutions were
made according to manufacturer specifications. Stock solutions of KT-5720
and forskolin were made by dissolution in DMSO (Sigma). The concentration
of DMSO in the external solution was < 0.1%. Stock solutions of MTII were
made by dissolution in PBS (GIBCO). Stock solutions of THIQ, TTX, CNQX,
AP-5, picrotoxin, H-89, and 8-Br-cAMP were made by dissolution in deionized
water.
Radiotelemetry
Micewere surgically fitted with a Data Sciences International (Minnesota, USA)
TAIIPA-C10 small rodent radio transmitter in the left carotid artery. Ten days
after recovery, single-caged mice were placed on receiver pads in their
home cage with free access to food and water. Data were collected and
analyzed using Dataquest A.R.T. 4.0 software (DSI, Minnesota, USA). Baseline
cardiovascular measurements were taken for 5 min every hour over a 72 hr
period, separated into light (7 a.m. – 5 p.m.) and dark (7 p.m. – 5 a.m.) phase,
and averaged over the 72 hr.
Basal Insulin Levels
Basal insulin levels weremeasured in male mice at 3months of age. Mice were
transferred to a clean cage containing water but no food at 8 a.m. to begin
a 5 hr fast. Blood sampleswere then collected from the cut tail and centrifuged,
and plasma was removed as the supernatant. Plasma insulin levels were
measured using an ELISA kit (Crystal Chem, Downers Grove, IL) according
to manufacturer’s instruction.
Data Analysis
Statistical data are expressed as means ± SEM, where n represents the
number of cells studied. The significance of differences between measure-
ments was evaluated using unpaired two-tailed Student’s t test with a confi-
dence level of p < 0.05 (*) or p < 0.01 (**). For Figures 5A and 5B significance
was evaluated using one-way ANOVA or two-way repeated-measures
ANOVA, respectively, with relevant post hoc tests. For the analysis of
PSCs, at least 2 min recording of mEPSCs and mIPSCs was examined to
identify drug effects on amplitude and frequency distributions. A value of
twice the mean peak-to-peak noise level for a given recording in control
solutions was used as the detection limit for minimal PSC amplitude (i.e.,
typically 5–10 pA). Drug effects on miniature PSC frequency before
and during drug application were analyzed within a recording using
the Kolmogorov-Smirnov (K-S) test (a nonparametric, distribution-free618 Cell 152, 612–619, January 31, 2013 ª2013 Elsevier Inc.goodness-of-fit test for probability distributions). Pooled results of miniature
PSC frequency and drug effects on mean amplitude of miniature PSCs were
analyzed using a paired two-tailed t test with a confidence level of p < 0.05
(*) or p < 0.01 (**).
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